Your browser doesn't support javascript.
loading
Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF).
Hiligsmann, M; Cornelissen, D; Vrijens, B; Abrahamsen, B; Al-Daghri, N; Biver, E; Brandi, M L; Bruyère, O; Burlet, N; Cooper, C; Cortet, B; Dennison, E; Diez-Perez, A; Gasparik, A; Grosso, A; Hadji, P; Halbout, P; Kanis, J A; Kaufman, J M; Laslop, A; Maggi, S; Rizzoli, R; Thomas, T; Tuzun, S; Vlaskovska, M; Reginster, J Y.
Affiliation
  • Hiligsmann M; Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, P.O. Box 616, 6200 MD, Maastricht, the Netherlands. m.hiligsmann@maastrichtuniversity.nl.
  • Cornelissen D; Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, P.O. Box 616, 6200 MD, Maastricht, the Netherlands.
  • Vrijens B; Research and Development, AARDEX Group and Department of Public Health, University of Liège, Liege, Belgium.
  • Abrahamsen B; Open Patient Data Explorative Network, Institute of Clinical Resesarch, University of Southern Denmark, Odense, Denmark.
  • Al-Daghri N; Department of Medicine, Holbæk Hospital, Holbæk, Denmark.
  • Biver E; NDORMS, University of Oxford, Oxford, UK.
  • Brandi ML; Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia.
  • Bruyère O; Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
  • Burlet N; FirmoLab, Fondazione FIRMO e Università di Firenze, Florence, Italy.
  • Cooper C; Division of Public Health, Epidemiology and Health Economics, Liège, Belgium and WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging, University of Liège, Liege, Belgium.
  • Cortet B; Global Head of Patient Insights Innovation, Patient Solution Unit, Sanofi, Lyon, France.
  • Dennison E; MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, Southampton, UK.
  • Diez-Perez A; NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK.
  • Gasparik A; Department of Rheumatology and EA 4490, University-Hospital of Lille, Lille, France.
  • Grosso A; MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, Southampton, UK.
  • Hadji P; Musculoskeletal Research Unit, IMIM-Parc Salut Mar, CIBERFES, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Halbout P; Department of Public Health, University of Medicine, Pharmacy, Science and Technology of Targu Mures, Targu Mures, Romania.
  • Kanis JA; Patient partner, Geneva, Switzerland.
  • Kaufman JM; Frankfurt Centre of Bone Health, Frankfurt, Germany & Philips-University of Marburg, Marburg, Germany.
  • Laslop A; International Osteoporosis Foundation, Nyon, Switzerland.
  • Maggi S; Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.
  • Rizzoli R; Mary McKillop Health Institute, Catholic University of Australia, Melbourne, Australia.
  • Thomas T; Department of Endocrinology, Ghent University Hospital, Ghent, Belgium.
  • Tuzun S; Scientific Office, Austrian Federal Office for Safety in Health Care, Vienna, Austria.
  • Vlaskovska M; CNR Aging Branch-NI, Padua, Italy.
  • Reginster JY; Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Osteoporos Int ; 30(11): 2155-2165, 2019 Nov.
Article in En | MEDLINE | ID: mdl-31388696
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Medication Adherence Type of study: Etiology_studies / Guideline / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Systematic_reviews Aspects: Determinantes_sociais_saude Limits: Humans Country/Region as subject: Europa Language: En Journal: Osteoporos Int Journal subject: METABOLISMO / ORTOPEDIA Year: 2019 Document type: Article Affiliation country: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Medication Adherence Type of study: Etiology_studies / Guideline / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Systematic_reviews Aspects: Determinantes_sociais_saude Limits: Humans Country/Region as subject: Europa Language: En Journal: Osteoporos Int Journal subject: METABOLISMO / ORTOPEDIA Year: 2019 Document type: Article Affiliation country: Netherlands